Theravance Biopharma TBPH
TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Net Debt Issuances and Repayments (2020 - 2021)

Updated

Analysis

Theravance Biopharma (TBPH) Net Debt Issuances and Repayments (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -4.36 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -2.00 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -2.46 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn 64.00 Mn
10 Theravance Biopharma 883.70 Mn -543.66 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -5.03 Mn
Mar 31, 2021 -5.70 Mn
Mar 31, 2020 144.65 Mn
API Access

Theravance Biopharma Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=TBPH&period=max&api_key=YOUR_API_KEY